Evaluation of the mortality rate caused by different periods of selective portal vein occlusion in rats / Avaliação da mortalidade causada por diferentes períodos de oclusão seletiva da veia porta em ratos

Mortality from acute selective portal vein occlusion (SPVO) is a matter of concern for surgeons during the management of traumatic portal vein injury. However, mortality rates related to different periods of SPVO remains undetermined. PURPOSE: To determine the mortality rates resulting from different periods of acute SPVO in rats. METHODS: Wistar male rats were randomized into 8 experimental, and 8 control groups. Experimental animals underwent SPVO during 15 to 75 minutes, and control groups underwent sham procedures. All surviving animals were followed up to 14 days for assessment of mortality rate. RESULTS: Death rates varied from 0 percent in the 15 min SPVO group, to 100 percent with 65 and 75 minutes of SPVO. A strongly positive correlation was observed between mortality rates and SPVO periods (p 30 min) of SPVO.

A mortalidade da oclusão seletiva da veia porta (OSVP) preocupa os cirurgiões durante o tratamento de lesão traumática da veia porta. Entretanto, as taxas de mortalidade decorrentes de diferentes períodos de OSVP não estão determinadas. OBJETIVO: Determinar a mortalidade Decorrente de diferentes períodos de oclusão seletiva da veia porta (OSVP) em ratos. MÉTODOS: Ratos Wistar machos foram randomizados em 8 grupos experimentais e 8 controles. Os experimentais foram submetidos a OSVP por períodos de 15 a 75 minutos, seguidos de observação até o óbito, e os sobreviventes até 14 dias. Os grupos controles receberam idênticos procedimentos, exceto a OSVP. RESULTADOS: A mortalidade, a partir do momento da oclusão, aumentou progressivamente, de 0 por cento no grupo de 15min, atingindo 100 por cento nos grupos de 65min e 75min de OSVP. Houve alta correlação positiva entre mortalidade e duração da OSVP (p 30 minutos).

Evaluation of the mortality rate caused by different periods of selective portal vein occlusion in rats

Mortality from acute selective portal vein occlusion (SPVO) is a matter of concern for surgeons during the management of traumatic portal vein injury. However, mortality rates related to different periods of SPVO remains undetermined. PURPOSE: To determine the mortality rates resulting from different periods of acute SPVO in rats. METHODS: Wistar male rats were randomized into 8 experimental, and 8 control groups. Experimental animals underwent SPVO during 15 to 75 minutes, and control groups underwent sham procedures. All surviving animals were followed up to 14 days for assessment of mortality rate. RESULTS: Death rates varied from 0 percent in the 15 min SPVO group, to 100 percent with 65 and 75 minutes of SPVO. A strongly positive correlation was observed between mortality rates and SPVO periods (p<0.001) with either linear or quadratic regression analysis tests. All deaths in the 20min and 25min SPVO groups occurred after 75 min from the moment of clamping (or after 60 min from unclamping); death from 30 or more min SPVO occurred predominantly within 75 min from clamping moment (or within 60 min from unclamping). (Exact Fisher test, p=0.009). CONCLUSIONS: The mortality from SPVO in rats increases with longer duration of SPVO; with deaths occurring later for short periods (< 25 min) of SPVO and earlier for longer periods (> 30 min) of SPVO.

A mortalidade da oclusão seletiva da veia porta (OSVP) preocupa os cirurgiões durante o tratamento de lesão traumática da veia porta. Entretanto, as taxas de mortalidade decorrentes de diferentes períodos de OSVP não estão determinadas. OBJETIVO: Determinar a mortalidade Decorrente de diferentes períodos de oclusão seletiva da veia porta (OSVP) em ratos. MÉTODOS: Ratos Wistar machos foram randomizados em 8 grupos experimentais e 8 controles. Os experimentais foram submetidos a OSVP por períodos de 15 a 75 minutos, seguidos de observação até o óbito, e os sobreviventes até 14 dias. Os grupos controles receberam idênticos procedimentos, exceto a OSVP. RESULTADOS: A mortalidade, a partir do momento da oclusão, aumentou progressivamente, de 0 por cento no grupo de 15min, atingindo 100 por cento nos grupos de 65min e 75min de OSVP. Houve alta correlação positiva entre mortalidade e duração da OSVP (p<0.001; tanto em teste de Regressão linear quanto quadrática). Os óbitos decorrentes de 20 e 25 min de OSVP ocorreram após 75min do clampeamento (ou após 60 min do desclampeamento); os decorrentes de 30min ou mais ocorreram predominantemente antes de decorridos 75 min do clampeamento (ou 60 min do desclampeamento). (Teste exato de Fisher, p<0.05). CONCLUSÕES: A mortalidade da OSVP em ratos aumenta com a maior duração da oclusão; os óbitos ocorrem mais tardiamente após oclusões breves (< 25 min), e mais precocemente nas oclusões mais prolongadas (> 30 minutos).

Evaluation of the mortality rate caused by different periods of selective portal vein occlusion in rats.

UNLABELLED: Mortality from acute selective portal vein occlusion (SPVO) is a matter of concern for surgeons during the management of traumatic portal vein injury. However, mortality rates related to different periods of SPVO remains undetermined. PURPOSE: To determine the mortality rates resulting from different periods of acute SPVO in rats. METHODS: Wistar male rats were randomized into 8 experimental, and 8 control groups. Experimental animals underwent SPVO during 15 to 75 minutes, and control groups underwent sham procedures. All surviving animals were followed up to 14 days for assessment of mortality rate. RESULTS: Death rates varied from 0% in the 15 min SPVO group, to 100% with 65 and 75 minutes of SPVO. A strongly positive correlation was observed between mortality rates and SPVO periods (p<0.001) with either linear or quadratic regression analysis tests. All deaths in the 20 min and 25 min SPVO groups occurred after 75 min from the moment of clamping (or after 60 min from unclamping); death from 30 or more min SPVO occurred predominantly within 75 min from clamping moment (or within 60 min from unclamping). (Exact Fisher test, p=0.009). CONCLUSIONS: The mortality from SPVO in rats increases with longer duration of SPVO; with deaths occurring later for short periods (or= 30 min) of SPVO.

Left hemidiaphragmatic mobility: assessment with ultrasonographic measurement of the craniocaudal displacement of the splenic hilum and the inferior pole of the spleen.

OBJECTIVE: The purpose of this study was to evaluate the correlation between the radiographic and ultrasonographic measurements of craniocaudal displacement of the left hemidiaphragm. METHODS: Forty-nine patients with clinical indications for interventional procedures prospectively underwent radiographic evaluation of left hemidiaphragmatic mobility and B-mode ultrasonographic measurement of craniocaudal displacement of the hilum and the inferior pole of the spleen. Ultrasonography was performed with a 3.5-MHz convex transducer in a left intercostal position under a longitudinal orientation. Statistical analyses were performed with linear regression, a paired Student t test, and Bland-Altman analyses. RESULTS: The correlation between the craniocaudal splenic hilum displacement and radiographic measurements was found to be linear: hemidiaphragmatic mobility = 17.795 + 0.429 x splenic hilum displacement (SE for the regression coefficient = 0 .12; P = .0012), although the values obtained with both methods were statistically different (P < .05). The same results could be observed with the use of the inferior pole of the spleen: hemidiaphragmatic mobility = 9.5596 + 0.5455 x inferior polo displacement (SE for the regression coefficient = 0 .11; P < .0001). The mean difference between the values obtained by ultrasonography and by radiography was statistically significant (16.7 +/- 16.1 mm; P < .05 [hilum]; 18.9 +/- 14.2 mm; P < .05 [inferior pole]). CONCLUSIONS: These results allow us to conclude that ultrasonography can be used as an alternative method for left hemidiaphragm mobility evaluation compared with radiography.

Risk factors for development of acute renal failure after liver transplantation.

BACKGROUND: Acute renal failure (ARF) is a common complication after liver transplantation (LTx). Identification of risk factors may prevent the development and attenuate the impact of ARF on patients outcome after LTX. METHODS: Retrospective analysis of variables in the pre, intra, and postoperative periods of 92 patients submitted to LTx was performed in order to identify risk factors for development of ARF after LTx. ARF was defined as serum creatinine > or = 2.0 mg/dL in the first 30 days after LTx. Univariate and multivariate analysis by logistic regression were performed. RESULTS: ARF group comprised 56 patients (61%). Preoperative serum creatinine was higher in ARF group. During the intraoperative period, ARF group required more blood transfusions, developed more episodes of hypotension and presented longer anesthesia time. In the postoperative period, ARF group presented higher serum bilirubin and more episodes of hypotension. Dialysis was required in 10 patients (11%). The identifled risk factors for development of ARF were: preoperative serum creatinine > 1.0 mg/dL. more than five blood transfusions in the intraoperative period, hypotension during intra and postoperative periods. The identified mortality risk factors were hypotension in the postoperative period and no recovery of renal function after 30 days. CONCLUSIONS: Several factors are involved in the pathogenesis of ARF after LTx and may influence patients outcome and mortality. Pretransplant renal function and hemodynamic conditions in the operative and postoperative periods were identified as risk factors for development of ARF after LTx. Nonrenal function recovery and postoperative hypotension were identified as mortality risk factors after LTx.

Right hemidiaphragmatic mobility: assessment with US measurement of craniocaudal displacement of left branches of portal vein.

PURPOSE: To evaluate the correlation and agreement between ultrasonographic (US) measurement of craniocaudal displacement of the left intrahepatic branches of the portal vein and radiographic measurement of right hemidiaphragmatic mobility. MATERIALS AND METHODS: Fifty-one patients with indications for abdominal angiography or percutaneous cholangiography prospectively underwent radiographic evaluation of right hemidiaphragmatic mobility and B-mode US measurement of craniocaudal displacement of the left intrahepatic branches of the portal vein. US was performed by using a 3.5-MHz convex transducer in a right subcostal position with a longitudinal orientation. Statistical analyses were performed by using linear regression, paired Student t test, and Bland-Altman analyses. RESULTS: The correlation between the US and radiographic measurements was found to be linear: hemidiaphragmatic mobility = (-1.562 + 1.032) x portal vein branch displacement (r = 0.651, P <.001). The mean craniocaudal displacement of the intrahepatic branches of the portal vein measured at US was 35.2 mm +/- 10.7 (SD). The mean right hemidiaphragmatic mobility measured at radiography was 34.8 mm +/- 17.0. The mean difference between the two measurements was not statistically significant (0.4 mm +/- 12.9, P =.807). CONCLUSION: US measurement of craniocaudal displacement of the left intrahepatic branches of the portal vein can be used for indirect assessment of right hemidiaphragmatic mobility.

Hepatites B e C na esquistossomose mansoni / B and C Hepatitis in schistosomiasis mansoni

Foram estudados 234 pacientes com essquistossomose mansoni, sendo 44 com a forma hepatintestinal (EHI), 143 com a forma hepatesplenica compensada (EHEC) e 47 com a forma descompensada (EHED), além de 50 individuos controles. Dos 234 pacientes, 133 (57por cento) tinham pelo menos um marcador sorológico dis HBV e hcv. A frequencia do HBsAg foi significativamente maior (21por cento vs. 6por cento vs. 2por cento) nos com EHED do que nos com EHEC ou nos com EHI (p<0,001. Dos 19 (8por cento) AgHBs positivos,14 (74por cento) foram ant-HBe (um com EHI, sete com EHEC e seis com EHED),incluindo sete (37 por cento) HBV-DNA positivos. Em relaçao ao HCV, 47 (20por cento) dos 234 pacientes foram anti-HCV poistivos, apresentaram também HCV-RNA no soro, sendo11 (69,8 por cento) dos 16 com EHEC,17 (56,7 por cento) dos com EHED e um com EHI. O HCV_DNA foi detectado tambem em cinco pacientes anti-HCV negativos com EHED, totalizando 22 pacientes cm infeccao pelo HCV. Nos 108 pacientes com EHE ( 13 HBsAg positivos, 25 anti-HCV positivos para ambos os marcadores submetidos a esplenectomia) em que foi realizada biópsia hepatica dos com EHEC apresentava hepatite cronica ativa. Os achados deste estudo sugerem que a infecçao concomitante pelos virus das hepatites B e C é importante fator contribuinte para a gravidade da doença hepatica na esquistossomose mansoni